e-learning
resources
Munich 2006
Tuesday 05.09.2006
Inflammatory markers and experimental studies in occupational and environmental diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung inflammation promotes arterial thrombosis
via
P-selectin: a study with carbon nanotubes in mice
A. Nemmar, M. F. Hoylaerts, P. H. M. Hoet, B. Nemery (Leuven, Belgium)
Source:
Annual Congress 2006 - Inflammatory markers and experimental studies in occupational and environmental diseases
Session:
Inflammatory markers and experimental studies in occupational and environmental diseases
Session type:
Poster Discussion
Number:
3621
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Nemmar, M. F. Hoylaerts, P. H. M. Hoet, B. Nemery (Leuven, Belgium). Lung inflammation promotes arterial thrombosis
via
P-selectin: a study with carbon nanotubes in mice. Eur Respir J 2006; 28: Suppl. 50, 3621
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Pulmonary artery endothelial cell exposure to hepcidin affects BMP-signalling; relevance to vascular remodelling in PAH
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005
MicroRNA-155 controls pulmonary artery fibroblast cell signalling and proliferation in a knockout mouse model: A role in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Inflammation in pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: 358-363
Year: 2003
Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
CCR7 deficiency induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
LATE-BREAKING ABSTRACT: TNFalpha mediates ectodomain shedding of BMPR-II: A potential role in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with
BMPR2
mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study
Source: Eur Respir J 2002; 20: 332-338
Year: 2002
Correlation of inhaled nitric-oxide induced reduction of pulmonary artery pressure and vascular changes
Source: Eur Respir J 2002; 20: 52-58
Year: 2002
Vascular cell adhesion molecules-1 expression changes in lipopolysaccharide initiated pulmonary inflammation in endotoxin tolerance rats
Source: Eur Respir J 2005; 26: Suppl. 49, 406s
Year: 2005
Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
Endothelial cell mechanics are altered in pulmonary arterial hypertension (PAH)
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept